Penbrook Management’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.06M Sell
10,895
-1,200
-10% -$178K 1.32% 21
2026
Q1
$1.13M Sell
12,095
-3,800
-24% -$337K 0.85% 34
2025
Q4
$1.28M Sell
15,895
-1,000
-6% -$83.7K 0.88% 27
2025
Q3
$1.65M Sell
16,895
-19,640
-54% -$1.58M 1.15% 21
2025
Q2
$2.15M Buy
36,535
+16,895
+86% +$964K 0.81% 31
2025
Q1
$976K Buy
19,640
+75
+0.4% +$4.74K 0.74% 38
2024
Q4
$1.37M Hold
19,565
0.93% 25
2024
Q3
$2.05M Sell
19,565
-3,360
-15% -$393K 1.33% 12
2024
Q2
$3.26M Sell
22,925
-19,535
-46% -$2.25M 1.99% 9
2024
Q1
$4.74M Sell
42,460
-580
-1% -$69.1K 2.93% 5
2023
Q4
$5.58M Sell
43,040
-550
-1% -$75.8K 3.75% 4
2023
Q3
$7.11M Sell
43,590
-1,035
-2% -$182K 5.21% 3
2023
Q2
$8.18M Sell
44,625
-2,685
-6% -$387K 5.93% 3
2023
Q1
$6.3M Sell
47,310
-365
-0.8% -$42.9K 4.83% 3
2022
Q4
$3.78M Hold
47,675
3.22% 5
2022
Q3
$2.89M Sell
47,675
-250
-0.5% -$16.1K 2.48% 9
2022
Q2
$2.63M Sell
47,925
-225
-0.5% -$13K 2.07% 9
2022
Q1
$3.64M Sell
48,150
-14,150
-23% -$967K 2.36% 7
2021
Q4
$4.64M Sell
62,300
-1,500
-2% -$88.9K 2.8% 5
2021
Q3
$3M Sell
63,800
-750
-1% -$32.6K 1.86% 9
2021
Q2
$2.61M Sell
64,550
-1,250
-2% -$51.8K 1.56% 14
2021
Q1
$2.7M Sell
65,800
-5,950
-8% -$222K 1.95% 10
2020
Q4
$2.09M Hold
71,750
1.61% 15
2020
Q3
$1.58M Buy
71,750
+150
+0.2% +$3.83K 1.37% 20
2020
Q2
$1.99M Sell
71,600
-9,000
-11% -$219K 1.96% 10
2020
Q1
$1.48M Sell
80,600
-5,925
-7% -$138K 1.89% 9
2019
Q4
$2.08M Sell
86,525
-300
-0.3% -$6.32K 2.03% 7
2019
Q3
$1.48M Sell
86,825
-700
-0.8% -$11.2K 1.61% 14
2019
Q2
$1.32M Hold
87,525
1.41% 17
2019
Q1
$1.76M Sell
87,525
-4,675
-5% -$94.9K 1.83% 12
2018
Q4
$1.64M Hold
92,200
1.87% 13
2018
Q3
$1.81M Sell
92,200
-350
-0.4% -$7.21K 1.73% 14
2018
Q2
$1.83M Hold
92,550
1.76% 13
2018
Q1
$2.28M Sell
92,550
-4,255
-4% -$112K 2.28% 9
2017
Q4
$2.78M Buy
+96,805
New +$3.05M 2.5% 7
2016
Q3
$1.63M Hold
122,360
1.75% 13
2016
Q2
$1.32M Sell
122,360
-500
-0.4% -$5.36K 1.45% 17
2016
Q1
$1.38M Sell
122,860
-5,750
-4% -$58.8K 1.52% 17
2015
Q4
$1.33M Sell
128,610
-1,725
-1% -$18.3K 1.37% 23
2015
Q3
$1.39M Sell
130,335
-1,830
-1% -$22.3K 1.47% 22
2015
Q2
$1.56M Sell
132,165
-180
-0.1% -$2.08K 1.49% 17
2015
Q1
$1.26M Sell
132,345
-430
-0.3% -$4.44K 1.12% 32
2014
Q4
$1.36M Hold
132,775
1.23% 32
2014
Q3
$1.06M Hold
132,775
0.97% 39
2014
Q2
$1.06M Sell
132,775
-126,725
-49% -$945K 0.94% 40
2014
Q1
$2.38M Buy
259,500
+129,175
+99% +$1.19M 1.14% 29
2013
Q4
$1.27M Buy
+130,325
New +$1.18M 1.23% 28

Other funds holding ACLS

Penbrook Management's ACLS Position: Q2 2026 in Review

Penbrook Management reduced its Axcelis (ACLS) stake by 9.9% in Q2 2026, selling an estimated $178K and leaving 10,895 shares worth $2.06M. The position accounts for 1.32% of the portfolio, ranked #21.

Penbrook Management first reported a position in ACLS in Q4 2013 and has held it in 47 quarters since. The position peaked at $8.18M in Q2 2023. 439 funds tracked by Wall St. Rank hold ACLS as of Q2 2026.

  • Penbrook Management held 10,895 shares of Axcelis worth $2.06M as of Q2 2026.
  • Penbrook Management sold 1,200 Axcelis shares in Q2 2026, an estimated $178K.
  • Axcelis made up 1.32% of Penbrook Management's portfolio in Q2 2026, its #21 holding.
  • Penbrook Management first reported a position in Axcelis in Q4 2013 and has held it in 47 quarters since.
  • Penbrook Management's Axcelis position peaked at $8.18M in Q2 2023.
  • 439 funds tracked by Wall St. Rank held Axcelis as of Q2 2026.

Based on Penbrook Management's 13F filing for Q2 2026, filed 23 Jul 2026.